Global Contraceptive Drugs And Devices Market Outlook 2025-2034: Trends, Innovations, And Future Outlook

Our market reports now include the latest updates on global tariffs, trade impacts, and evolving supply chain dynamics.

What Is the Contraceptive Drugs And Devices Market Size and Projected Growth Rate?
In recent times, there has been significant growth in the market size of contraceptive drugs and devices. The market, which is projected to escalate from $25.30 billion in 2024 to $27.24 billion in 2025, will be growing at a compound annual growth rate (CAGR) of 7.7%. Factors that contributed to this growth in the historical period include an increase in population, more awareness about family planning, government-driven initiatives and funding, a rise in the number of employed women, and technological advancements in contraception.

In the coming years, the market size for contraceptive drugs and devices is projected to experience robust growth. The market is predicted to rise to $36.31 billion by 2029, with a compound annual growth rate (CAGR) of 7.5%. This growth in the forecast period can be attributed to reasons such as increasing demand for long-term reversible contraceptives, heightened emphasis on women's reproductive health, growing occurrences of sexually transmitted infections, broader access to ecommerce and telehealth services, healthcare policies that are supportive, and insurance coverage. Key trends forecasted for this period include contraceptive devices equipped with digital tracking, biodegradable implants and patches, innovations in hormone-free contraceptives, fertility monitoring apps powered by AI, and 3D printing of bespoke contraceptive devices.

Purchase the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/customise?id=24197&type=smp

What Are the Major Segments in the Contraceptive Drugs And Devices Market?
The contraceptive drugs and devices market covered in this report is segmented -

1) By Product: Contraceptive Drugs, Contraceptive Devices
2) By Technology: Traditional Methods, Digital Contraceptive Apps, Wearable Devices, Long-Acting Reversible Contraceptives (LARCs)
3) By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Clinics, Online Channels, Public Channels And Non-Governmental Organizations, Other Distribution Channels
4) By End User: Male, Female

Subsegments:
1) By Contraceptive Drugs: Oral Contraceptive Pills, Injectable Contraceptives, Contraceptive Patches, Vaginal Rings, Emergency Contraceptive Pills, Hormonal Implants
2) By Contraceptive Devices: Male Condoms, Female Condoms, Intrauterine Devices (IUDs), Diaphragms And Cervical Caps, Contraceptive Sponges, Sterilization Devices

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=24197&type=smp

What Are The Driving Contraceptive Drugs And Devices Market Evolution?
Anticipated growth in the contraceptive drugs and devices market is largely attributed to the growing number of government reproductive health initiatives. These government-led efforts aim to foster reproductive health through improved awareness, provision of funds, and accessibility to services. The prevalence of such initiatives is due to an increased understanding of the importance of addressing matters pertaining to maternal health, family planning, and access to critical healthcare services, all of which contribute to societal welfare and advancement. These government-driven programs for contraceptive drugs and devices are designed to broaden access to affordable and efficient family planning practices, ensuring that individuals can make knowledgeable choices about their reproductive health. For instance, come November 2024, the Australian Government Department of Foreign Affairs and Trade, an Australia-based government agency, plans to allocate $56.8 million towards a new project aimed at encouraging sexual and reproductive health and rights in Southeast Asia. In view of this, the escalating number of government initiatives relating to reproductive health is fuelling the development of the contraceptive drugs and devices market.

Which Firms Dominate The Contraceptive Drugs And Devices Market Segments?
Major companies operating in the contraceptive drugs and devices market are Pfizer Inc., Johnson & Johnson Services Inc., Merck & Co Inc., Bayer AG, Viatris Inc., Teva Pharmaceuticals Ltd, Lupin Limited, CooperSurgical Inc., Mithra Pharmaceuticals, DKT International, Fuji Latex Co Ltd, Agile Therapeutics Inc., Cupid Limited, Veru Inc., Eskag Pharma Pvt. Ltd., Biosante Pharmaceuticals Inc., HLL Lifecare Limited, Afaxys Inc., The Female Health Company (FC2), Mayer Laboratories Inc., Daré Bioscience Inc.

What Contraceptive Drugs And Devices Market Trends Are Gaining Traction Across Different Segments?
Leading businesses in the contraceptive drugs and devices market are focusing on the creation of novel items such as contraceptive vaginal rings with the aim of improving usability and broadening a range of long-lasting contraception. Contraceptive vaginal rings are flexible devices that release hormones and are inserted into the vagina to avert pregnancies by suppressing ovulation. For instance, Xiromed LLC, a pharmaceutical company based in the USA, introduced EnilloRing to the market in October 2023. This ring is a soft, flexible contraceptive vaginal gear planned for vaginal insertion where it gradually discharges a mixture of etonogestrel (a type of progestin) and ethinyl estradiol (a form of estrogen) over three weeks to inhibit ovulation. EnilloRing, a generic bioequivalent to NuvaRing, provides a practical, unobtrusive and affordable monthly birth control option for women. It removes the necessity for daily administration and it maintains NuvaRing's safety, efficiency and tolerability attributes.

Get the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/report/contraceptive-drugs-and-devices-global-market-report

Which Is The Largest Region In The Contraceptive Drugs And Devices Market?
North America was the largest region in the contraceptive drugs and devices market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the contraceptive drugs and devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Frequently Asked Questions:
1. What Is the Market Size and Growth Rate of the Contraceptive Drugs And Devices Market?
2. What is the CAGR expected in the Contraceptive Drugs And Devices Market?
3. What Are the Key Innovations Transforming the Contraceptive Drugs And Devices Industry?
4. Which Region Is Leading the Contraceptive Drugs And Devices Market?

Why This Report Matters:

Competitive overview: This report analyzes the competitive landscape of the 3D imaging software market, evaluating key players on market share, revenue, and growth factors.

Informed Decisions: Understand key strategies related to products, segmentation, and industry trends.

Efficient Research: Quickly identify market growth, leading players, and major segments.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.